Cost of Biosimilar Product Development

Department of Health and Human Services

Forecast Overview

NAICS
921190
Performance end
9/20247

The purpose of this project is to develop a valuation model for the decision to bring a biosimilar and interchangeable biological product to market

Source

Source
HHS SBCX Forecast Export
Source file
Forecast.csv
Official source
Agency forecast source
Last verified
2026-08-31

Agency-published contact: · Lydina.Battle@hhs.gov

Related Federal Entities